Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
European journal of clinical pharmacology - 79(2023), 8 vom: 02. Aug., Seite 1145-1146 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cattaneo, Dario [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4MT4VIE29P |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 03.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00228-023-03524-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358335388 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358335388 | ||
| 003 | DE-627 | ||
| 005 | 20240403234850.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00228-023-03524-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1362.xml |
| 035 | |a (DE-627)NLM358335388 | ||
| 035 | |a (NLM)37331988 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cattaneo, Dario |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Atazanavir Sulfate |2 NLM | |
| 650 | 7 | |a 4MT4VIE29P |2 NLM | |
| 650 | 7 | |a Salvia hispanica seed extract |2 NLM | |
| 650 | 7 | |a HIV Protease Inhibitors |2 NLM | |
| 650 | 7 | |a Pyridines |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Pagano, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Beltrami, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Micheli, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Gervasoni, Cristina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of clinical pharmacology |d 1971 |g 79(2023), 8 vom: 02. Aug., Seite 1145-1146 |w (DE-627)NLM000099538 |x 1432-1041 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2023 |g number:8 |g day:02 |g month:08 |g pages:1145-1146 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00228-023-03524-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2023 |e 8 |b 02 |c 08 |h 1145-1146 | ||